“…Up to date previous published articles found that many gene variations may associate with glioma risk, such as XRCC1 mutations, XRCC3 mutations, IDH mutations etc. The gene polymorphisms increased or decreased glioma sensibility by regulating the proliferation and apoptosis of cells (Das et al, 2013;Liang et al, 2013). (Das et al, 2013;Li et al, 2013b) (Shete et al, 2009;Wrensch et al, 2009;Jin et al, 2013;Li et al, 2013;Walcott et al, 2013;Walsh et al, 2013a;Walsh et al, 2013b).…”